Dr. Neel Sagar Talwar, MD

Dr. Talwar practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Talwar's NPI, 1477977114, was assigned on February 18, 2014. Dr. Talwar graduated from American University of Antigua College of Medicine in 2014. Dr. Talwar holds California license A168727.

Dr. Talwar's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Talwar's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Talwar is also affiliated with Pomona Valley Hospital Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Talwar to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Talwar practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Talwar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Talwar is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Talwar's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and lung cancer among the conditions Dr. Talwar treats.

CMS data shows 3,153 Medicare services from Dr. Talwar across 8 procedure codes in 2024, for 578 Medicare patients. Medicare paid $238,419 for them.

CMS counts 578 Medicare patients who saw Dr. Talwar in 2024. The largest group is 65 to 74, with 283 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Talwar's median patient age at 66, with 64% women.

In 2024, Dr. Talwar wrote 2,032 Medicare Part D claims for 270 patients. 73% of them were for generic drugs. CMS names the drug for 1,673 of them, across 46 drugs with 11 or more claims each, at $3,529,341 in total drug cost. In 2023, CMS named 986 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Talwar for performance year 2024, reported as part of a group. Dr. Talwar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Talwar as offering telehealth.

Dmand AI links 4 papers to Dr. Talwar, published from 2019 to 2024. Dr. Talwar's most frequent co-authors are Marc Justin Braunstein, MD, PhD, Saro Kasparian, MD and Ajaz M. Khan, MD.

CMS Open Payments shows 28 general payments to Dr. Talwar from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Daiichi Sankyo Inc. paid the most, $500.

Dr. Talwar graduated from American University of Antigua College of Medicine in 2014. Dr. Talwar is a member of ASCO.

Dr. Talwar is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.